Insider Buying: Teleflex Incorporated (NYSE:TFX) Director Acquires 1,000 Shares of Stock

Key Points

• Director Andrew A. Krakauer purchased 1,000 shares of Teleflex stock for $115.25 per share, totaling $115,250, increasing his position by 16.15% to a total of 7,192 shares.
• Teleflex reported earnings of $3.73 per share for the last quarter, surpassing analysts' expectations of $3.36 and achieving a revenue of $780.90 million.
• The company declared a quarterly dividend of $0.34 per share, scheduled to be paid on September 15, which reflects an annualized dividend of $1.36 and a yield of 1.2%.

Teleflex Incorporated (NYSE:TFX - Get Free Report) Director Andrew A. Krakauer acquired 1,000 shares of the stock in a transaction that occurred on Tuesday, August 5th. The shares were bought at an average price of $115.25 per share, for a total transaction of $115,250.00. Following the transaction, the director owned 7,192 shares of the company's stock, valued at $828,878. This trade represents a 16.15% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.

Teleflex Trading Down 0.7%

Shares of TFX stock traded down $0.85 on Monday, reaching $117.57. 16,693 shares of the stock were exchanged, compared to its average volume of 801,558. Teleflex Incorporated has a one year low of $108.90 and a one year high of $249.90. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.41 and a quick ratio of 1.44. The stock has a market cap of $5.20 billion, a PE ratio of 27.83, a P/E/G ratio of 1.65 and a beta of 1.08. The stock has a 50 day moving average price of $118.09 and a 200 day moving average price of $134.28.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, topping analysts' consensus estimates of $3.36 by $0.37. Teleflex had a return on equity of 15.08% and a net margin of 6.31%. The company had revenue of $780.90 million for the quarter, compared to analyst estimates of $771.53 million. During the same quarter last year, the company earned $3.42 earnings per share. The firm's quarterly revenue was up 4.2% compared to the same quarter last year. Equities research analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Friday, August 15th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend is Friday, August 15th. Teleflex's payout ratio is currently 32.00%.

Hedge Funds Weigh In On Teleflex

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Headlands Technologies LLC bought a new position in shares of Teleflex during the 4th quarter valued at about $29,000. Banque Cantonale Vaudoise purchased a new stake in Teleflex in the 1st quarter worth approximately $27,000. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Teleflex by 103.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock valued at $27,000 after purchasing an additional 100 shares during the period. Costello Asset Management INC purchased a new position in shares of Teleflex in the 1st quarter valued at approximately $28,000. Finally, Brooklyn Investment Group increased its position in Teleflex by 258.6% during the 1st quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company's stock valued at $29,000 after buying an additional 150 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on TFX shares. Mizuho raised their target price on shares of Teleflex from $130.00 to $135.00 and gave the company a "neutral" rating in a research report on Friday, August 1st. Wells Fargo & Company decreased their target price on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a research report on Friday, August 1st. Wall Street Zen upgraded shares of Teleflex from a "hold" rating to a "strong-buy" rating in a research note on Saturday, August 2nd. Truist Financial reduced their target price on Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a report on Monday, May 5th. Finally, Royal Bank Of Canada lifted their price target on Teleflex from $130.00 to $135.00 and gave the company a "sector perform" rating in a report on Friday, August 1st. One analyst has rated the stock with a sell rating, eight have assigned a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Teleflex currently has an average rating of "Hold" and an average price target of $141.57.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.